Equities researchers at William Blair decreased their Q1 2025 earnings per share estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. William ...

Sharemarket seesaws; CSL tumbles on sales blow; gold buoys Evolution, De Grey; impairment hit for Ramsay; upgrades on the horizon for Breville.

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Shares of Incyte (INCY) fell 6% Monday after the company released its Q4 earnings report and 2025 sales forecast. Read more ...

The flat finish reflects Wall Street, which seemed to be taking President Donald Trump’s latest tariff push in stride, with ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from ...